• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Public Health

Optimal 3-variable risk-adjustment model developed for use in global surgery outcomes research

bys25qthea
October 11, 2012
in Public Health, Surgery
Reading Time: 2 mins read
Share on FacebookShare on Twitter

Image: CC/ArmyMed

Key study points:

  1. This study compared models using a receiver operator curve analysis, and found that less than 6 variables are necessary to develop a risk-adjusted tool to predict inpatient mortality
  2. Most predictive model with highest area under the receiver operator curve was 3 variables: age, ASA classification, and functional status

Primer: The National Surgical Quality Improvement Program (NSQIP) in the U.S. collects preoperative variables used to develop models for predicting inpatient mortality. This tool has over 100 variables designed for collection in urban settings.  Resource poor areas, especially abroad, are limited in their ability to carry out risk-adjusted surgical outcomes research because of the complexity of the NSQIP and the difficulty in collecting all of the variables. The authors of this study set out to develop a model that is nearly as predictive but with less than 10 variables, which will be more capable of being utilized all over the world.

This [retrospective] study: Patient data from 2005 to 2009 in the NSQIP database was used, which measures over 130 variables and also records the 30-day mortality.  Variables from 631,449 patients in the database were considered.  From these variables, the authors used receiver-operator curves to determine which individual variables would contribute the most to the predictive nature of the models, with 1 being the most predictive value possible.

Authors sequentially went up to 6 variables, after first identifying ASA class as the most predictive and building on it using multivariate regression analyses. The model with the highest AUROC (0.9398) was only 3 variables and included ASA classification, age, and functional status.  There was also a 2 variable model with AUROC of 0.9290. Models with 4-6 variables had diminishing returns, and only changed the AUROC minimally.

In sum: This risk-adjustment model changes the difficulty and complexity of collecting data necessary for risk-adjusted outcomes research, and thus paves the way for more outcomes research globally in resource-poor settings.  It also greatly diminishes costs and the minimal technological requirements (e.g. electronic medical records) necessary to facilitate the collection of these variables, yet still maintains a significant predictive power for risk adjustments.  Its use of the NSQIP database, which comes from many centers, makes the results more applicable broadly.

RELATED REPORTS

The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar

Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma

Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging

One concern, which the authors acknowledge, is the critique that ASA classification is subjective and that inter-operator variability is high.  However, they suggest that each surgical program can use the model with limited variables of their choosing based on the report, whether it be the one with the highest AUROC or one of the other similarly predictive, but with more objective models.  Ultimately, the authors believe the strength of this study is that many of the models they provide with AUROC above 0.9 can be used adequately for risk-adjusted outcomes research to continue to advance surgical quality worldwide.

Click to read the study in JAMA

By [DM] and [AH]

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCLAIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

 

Previous Post

Novel endovascular devices for clot retrieval in acute ischemic stroke: The TREVO2 and SWIFT trials

Next Post

Combined BRAF and MEK inhibition in metastatic melanoma significantly improves progression free survival

RelatedReports

Imaging and Intervention

The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar

September 18, 2026
Chronic Disease

Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma

September 18, 2026
Artificial Intelligence

Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging

September 18, 2026
Chronic Disease

Brepocitinib becomes first oral therapy approved for adult dermatomyositis

September 18, 2026
Next Post

Combined BRAF and MEK inhibition in metastatic melanoma significantly improves progression free survival

Cognitive dysfunction is common in lacunar stroke patients

Effect of nonpayment for preventable infections in US hospitals

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.